Portea Medical, India’s largest outside of hospital consumer healthcare company, announced the appointment of the founder Meena Ganesh as the Chairperson and of Vaibhav Tewari as the company’s CEO. In her new capacity, Meena will be building strategy, M&A, driving advocacy and relationships with stakeholders such as Institutional partners, government bodies, investors and external communication. Vaibhav will be working on company growth, strategy roll-out, building business and deploying technologies.
The new appointments have been made with an aim to further synergize and streamline Portea’s operations in the new normal, and efficiently activate the 2023 growth strategy of the organization. As the leading brand in its domain, Portea is now all set to move forward with a three-pronged approach: Transform Current Business with Digital Adoption, Rapid Geographical Expansion and Digital Led Business.
Speaking about this, Meena Ganesh, Chairperson, Portea Medical, said, “In the wake of the pandemic, there has been a much greater adoption and demand for digital healthcare services. We, therefore, felt the need to further strengthen our digital capabilities and expand our footprint as well as our services’ portfolio. In the last one and a half years, we have worked closely with all stakeholders and served millions of people in various ways across the country. The situation has not only created a favourable atmosphere for digital healthcare in India but also clearly highlighted the areas where stronger digitization strategies are required. Vaibhav and I have worked in tandem since the outset, and now it is a great opportunity for us to take Portea forward with him as the CEO.”
Today, the Indian healthcare ecosystem is experiencing a major transformation with technology at the forefront. Covid-19 has brought healthcare into the focus in a big way and the government is investing significantly in healthcare infrastructure apart from making policy changes to make healthcare more accessible. Corporates are looking at employee’s health, a movement forward from only a wellness focus. Even consumer behaviour has changed irreversibly post the pandemic with everything from e-commerce to health going online and at home.
Adding further, Vaibhav Tewari, CEO, Portea Medical, said, “Portea is revolutionizing the Indian healthcare ecosystem by leveraging technology to innovate and provide patient-centric solutions at all times. During the pandemic, we supported COVID care through remote monitoring as well as on-ground deployment of resources, medical equipment and technology. In addition, we provided complex hospital-based procedures such as cancer care and dialysis at home. It is time now to further optimize the digital integration and bring in cutting-edge technologies to elevate the experience. We have created our strategic vision for 2023 with an aim to take our digital-first healthcare services to more people and territories across India. At the same time, we will use automation and other technologies to enhance the experience of people availing our services as well as our on-ground caregivers. Portea has achieved the leadership position courtesy of its service excellence and we plan to continue with this momentum.”
The digital healthcare market is expected to grow at a CAGR of 27% reaching 500 billion by 2024. Homecare is already emerging as an important offering in the healthcare ecosystem. Portea Medical has already introduced path-breaking services such as dialysis and cancer care at home, and now it is all set to strive ahead by expanding its footprint across the country. Portea plans to strengthen its remote monitoring teams and technology, create hybrid offerings that best use technology and on-ground presence
As India’s largest home healthcare player, Portea has been delivering consistent, high-quality patient care in various parts of the country. The company has catered to over 10 lakh patients in their home environment offering an extensive range of services for chronic diseases, elderly care, post-surgery care, diabetes management, chemotherapy at home, and other diseases or injuries requiring long-term care.
